ADENOVIRUS-MEDIATED TRANSFER OF A GENE ENCODING CHOLESTEROL 7-ALPHA-HYDROXYLASE INTO HAMSTERS INCREASES HEPATIC ENZYME-ACTIVITY AND REDUCESPLASMA TOTAL AND LOW-DENSITY-LIPOPROTEIN CHOLESTEROL
Dk. Spady et al., ADENOVIRUS-MEDIATED TRANSFER OF A GENE ENCODING CHOLESTEROL 7-ALPHA-HYDROXYLASE INTO HAMSTERS INCREASES HEPATIC ENZYME-ACTIVITY AND REDUCESPLASMA TOTAL AND LOW-DENSITY-LIPOPROTEIN CHOLESTEROL, The Journal of clinical investigation, 96(2), 1995, pp. 700-709
Clinical interventions that accelerate conversion of cholesterol to bi
le acids reduce circulating low density lipoprotein (LDL) cholesterol
concentrations, The initial and rate-limiting step in the bile acid bi
osynthetic pathway is catalyzed by hepatic cholesterol 7 alpha-hydroxy
lase. To examine the effects of transient primary overexpression of th
is enzyme on sterol metabolism and lipoprotein transport, we construct
ed a recombinant adenovirus in which a cDNA encoding rat 7 alpha-hydro
xylase is expressed from the human cytomegalovirus immediate-early pro
moter (AdCMV7 alpha). Syrian hamsters administered AdCMV7 alpha intrav
enously accumulated transgene-specific mRNA in the liver and demonstra
ted a dose-dependent increase in hepatic microsomal 7 alpha-hydroxylas
e activity, The increased conversion of cholesterol to bile acids resu
lted in a compensatory increase in hepatic cholesterol synthesis, In a
ddition, overexpression of 7 alpha-hydroxylase reduced the rate of LDL
cholesterol entry into the plasma space and, in animals maintained on
a Western-type diet, restored hepatic LDL receptor expression. As a c
onsequence, plasma LDL concentrations fell by similar to 60% in animal
s maintained on control diet and by similar to 75% in animals consumin
g a Western-type diet, Plasma high density lipoprotein cholesterol lev
els were reduced to a lesser degree. These results demonstrate that tr
ansient upregulation of bile acid synthesis by direct transfer of a 7
alpha-hydroxylase gene favorably alters circulating lipoprotein profil
es and suggest one potential molecular target for genetic strategies a
imed at reducing cardiovascular risk.